Principal Scientist
Oncology · Hong Kong · 2021-10-01
Proposed Endeavor
The petitioner proposes to continue using molecular biology, cancer immunology, and drug discovery techniques to identify mechanisms of cancer progression. Her work focuses on the development of new drug targets and treatment strategies to improve survival outcomes for patients, specifically targeting lung cancer through molecular profiling.
Framework Evaluation
3 of 3 criteria metThe research addresses cancer, one of the largest causes of death worldwide, and develops treatments for lung cancer.
The petitioner has a Ph.D. and a significant record of 515 citations and 29 peer review invitations.
On balance, the petitioner's unique contributions to oncology and drug discovery make her work beneficial to the U.S. without a labor certification.
Why This Petition Was Approved
Evidence
Similar Cases
Software Engineer
Artificial Intelligence · India
Management Consultant
Information Technology
Researcher
Healthcare
Others
Information Technology · China
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-10-01.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist